MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop
Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged ...
PharmaNest, a leader in high-resolution single-fiber digital pathology and AI, will present five communications at Digestive Disease Week (DDW) 2026, showcasing its advanced technologies for the study ...
Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases ...
Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory ...
Dr. Martin explains the role of biological age, NAD levels, and advanced diagnostics in guiding long-term health strategies. MIAMI BEACH, FL / ACCESS Newswire / April 24, 2026 / Dr. Alonso Martin, ...
Iridius, a compliance-by-design AI platform for regulated workflow execution, today announced it has raised $8.6 million in seed funding led by Chalfen Ventures, with participation from Osage Venture ...
"The Senior Care Influencer" joins forces with the free AI platform bringing caregivers immediate support, guidance, and hope. PHOENIX, AZ / ACCESS Newswire / April 24, 2026 / CaregiverCompanion.ai, ...
Eurofins Scientific SE (the “Company”) (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of ...
All Eyes on DME’ campaign aims to educate and empower people impacted by or at-risk for diabetic macular edema (DME)—a ...
If confirmed by the European Commission, REDEMPLO would be the first and only siRNA medicine authorized in the EU for both genetically confirmed and clinically diagnosed adult patients with FCS– ...
MESA, AZ / ACCESS Newswire / April 24, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today provided an operational update highlighting continued execution momentum and the expansion of its ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results